Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as a powder for oral solution for oral use. It is employed to relieve constipation and faecal impaction in adults and children when dietary measures are insufficient.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality assurance, regulatory compliance and reliable logistics for global distribution. Clients benefit from consistent product availability and dedicated technical support throughout the supply chain.

Movicol, an osmotic laxative, is indicated for conditions affecting bowel motility and stool consistency. - Constipation: softens stool and promotes regular bowel movements in adults and children with functional constipation. - Faecal impaction: increases intestinal water content to aid in the disintegration of impacted feces. - Chronic idiopathic constipation: provides long‑term relief by maintaining stool softness and ease of passage.

Movicol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Diarrhoea: loose, watery stools occurring more frequently. - Nausea: mild sensation of wanting to vomit. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium or potassium that may cause cardiac issues. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Movicol, consider the following precautions to ensure safe use. - Assess renal function: adjust use in patients with severe kidney impairment. - Monitor electrolyte status: prolonged use may affect sodium or potassium levels. - Use with caution in inflammatory bowel disease: may exacerbate symptoms. - Avoid in patients with known hypersensitivity to macrogol or any excipients. - Do not use in cases of intestinal obstruction without medical supervision. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Movicol can interact with other medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Concomitant use with high‑dose diuretics: may worsen electrolyte disturbances. - Co‑administration with other osmotic laxatives: can lead to excessive fluid loss.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may alter stool consistency. - Absorption‑dependent drugs (e.g., oral contraceptives, certain antibiotics): increased intestinal transit may reduce absorption. - NSAIDs: potential for reduced renal clearance when combined with fluid shifts.